These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9346373)

  • 1. Cytokines in severe infections: from pathophysiology to clinical applications.
    Glauser MP
    Eur Cytokine Netw; 1997 Sep; 8(3):317-8. PubMed ID: 9346373
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytokines and septic shock. New perspectives on its treatment].
    Zamora Madaria E
    An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic strategies to block LPS interactions with its receptor.
    Leturcq DJ; Moriarty AM; Talbott G; Winn RK; Martin TR; Ulevitch RJ
    Prog Clin Biol Res; 1995; 392():473-7. PubMed ID: 8524954
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii.
    Miech RP
    Ann Pharmacother; 2005 Sep; 39(9):1483-8. PubMed ID: 16046483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines, sepsis, and the surgeon: a perspective.
    Dudrick PS; Souba WW
    Surg Annu; 1994; 26():1-26. PubMed ID: 8303515
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interactions of cytokines with their receptors in the regulation of hematopoiesis, clinical and diagnostic applications].
    Koubek K; Skopový P; Vitek A; Jirásek A
    Sb Lek; 1998; 99(1):33-51. PubMed ID: 9748797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of monoclonal antibodies to lipopolysaccharide with the purpose of correction of cytokine activity in endotoxic shock in an acute experiment].
    Dubrovina ES; Blokhin BM; Aldonina VV; Anurov MG; Polivoda MD; Maiatnikov AIu; Ettinger AP
    Gematol Transfuziol; 1995; 40(5):36-8. PubMed ID: 8566659
    [No Abstract]   [Full Text] [Related]  

  • 8. The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock.
    Glauser MP
    Drugs; 1996; 52 Suppl 2():9-17. PubMed ID: 8869831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endotoxin and host cytokines in septic shock.
    Dunn DL
    Chest; 1991 Sep; 100(3 Suppl):164S-168S. PubMed ID: 1884642
    [No Abstract]   [Full Text] [Related]  

  • 10. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock.
    Boillot A; Capellier G; Racadot E; Wijdenes J; Herve P; Barale F
    Clin Intensive Care; 1995; 6(2):52-6. PubMed ID: 10150799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of cytokines in the development of local and systemic inflammation and septic shock].
    Bucová M
    Vnitr Lek; 2002 Aug; 48(8):755-62. PubMed ID: 12425207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Active mediators in the pathogenesis of septic shock and the importance of their neutralization in the treatment of patients].
    Bojić I
    Vojnosanit Pregl; 1996; 53(6):511-8. PubMed ID: 9229971
    [No Abstract]   [Full Text] [Related]  

  • 14. Anatomy of an antibody, and related misadventures in developing an effective treatment for septic shock.
    Gibaldi M
    Pharmacotherapy; 1993; 13(4):302-8. PubMed ID: 8361858
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokines and cytokine receptors.
    Trinchieri G
    Immunol Rev; 2004 Dec; 202():5-7. PubMed ID: 15546382
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibodies in the treatment of endotoxin shock (a review).
    Sinkovics JG
    Acta Microbiol Hung; 1990; 37(3):247-61. PubMed ID: 2100899
    [No Abstract]   [Full Text] [Related]  

  • 17. [Do we owe something?].
    Fomsgaard A
    Ugeskr Laeger; 2000 Jul; 162(27):3876-7. PubMed ID: 10920709
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing the treatment of a new horseman of the Apocalypse.
    Garnacho-Montero J; Ortiz-Leyba C
    Crit Care Med; 2007 Jun; 35(6):1626-7. PubMed ID: 17522542
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe sepsis and septic shock].
    Casanova MP; Peña JM; Rodríguez V; Ortega M; Celorrio LA
    Rev Esp Anestesiol Reanim; 2007 Oct; 54(8):484-98. PubMed ID: 17993098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pathophysiology-based approach to care of nuclear explosion victims.
    Gaffin SL
    Crit Care Med; 2007 Aug; 35(8):1998. PubMed ID: 17667257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.